免缝合/快速植入主动脉瓣与传统支架生物瓣的临床结局比较
基于STS成人心脏外科数据库,倾向性评分匹配后比较免缝合/快速植入瓣膜(SRD)与传统支架生物瓣(SBP)行主动脉瓣置换的30天结局。SRD组4486例,SBP组13215例。SRD组永久起搏器植入率更高(11.4% vs 4.9%),交叉钳夹时间更短(中位68 vs 86分钟),全胸骨切开更少(75% vs 77%),但30天死亡率(3.1% vs 3.1%)及中度以上瓣周漏(0.2% vs 0.1%)相似。
要点
- SRD瓣膜30天死亡率与SBP瓣膜相似(3.1% vs 3.1%,P=.98)。
- SRD组永久起搏器植入率显著高于SBP组(11.4% vs 4.9%,P<.001)。
- SRD组交叉钳夹时间更短(中位68 vs 86分钟,P<.001),全胸骨切开比例更低(75% vs 77%,P=.024)。
核心结论
- SRD植入与缩短手术时间和更小切口相关,30天死亡率、主要合并症及瓣周漏率与SBP相似,但永久起搏器植入率增加,需更长随访明确其意义。
研究设计与样本
- 基于STS成人心脏外科数据库的回顾性队列研究,排除经导管AVR病例,SRD与SBP按1:(最多)3比例行倾向性评分匹配,比较30天结局。
主要发现
- 匹配后SRD组4486例,SBP组13215例;SRD组永久起搏器植入率11.4% vs 4.9%(P<.001)。
- SRD组交叉钳夹时间中位68 vs 86分钟(P<.001),全胸骨切开比例75% vs 77%(P=.024)。
- 两组30天死亡率均为3.1%(P=.98),中度及以上瓣周漏0.2% vs 0.1%(P=.21)。
临床怎么用
- SRD瓣膜可缩短交叉钳夹时间并利于微创切口,但需权衡永久起搏器植入风险增加。
局限性
- 原文未报告具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sutureless/rapid-deployment (SRD) valves for aortic valve replacement (AVR) are new surgical bioprosthetic valves that allow for expedited implantation and facilitate minimally invasive approaches. Although clinical trial data are available for SRDs in the United States, how their clinical outcomes compare with traditional stented bioprosthetic (SBP) valves is unknown in a post-approval, commercial setting. METHODS: The Society of Thoracic Surgery Adult Cardiac Surgery Database was queried for patients who underwent an AVR. Transcatheter AVR cases were excluded. Thirty-day outcomes were compared between SRD valves (Perceval S [LivaNova, Houston, TX] and Intuity Elite [Edwards Lifesciences, Irvine CA]) and SBP valve patients. The SRD and SBP patients were propensity score-matched in a 1:(up to) 3 ratio. Primary outcome was 30-day mortality and secondary outcomes were major comorbidities, paravalvular regurgitation, and predischarge pacemaker implant. RESULTS: Propensity score matching resulted in 4486 SRD patients and 13,215 SBP patients. The SRD recipients had more permanent pacemakers (11.4% vs 4.9%, P < .001) shorter cross-clamp times (median: 68 vs 86 minutes, P < .001), and fewer full sternotomies (75% vs 77% , P < .024) than SBP but similar 30-day mortality (3.1% vs 3.1%, P = .98) and moderate or greater paravalvular regurgitation (0.2% vs 0.1%, P = .21). CONCLUSIONS: SRD implantation was associated with reduced operative times and smaller incisions. Rates of 30-day mortality, major comorbidities, and perivalvular regurgitation were similar between SRD and SBP patients. Longer follow-up is needed to determine the implications of increased permanent pacemaker implantation rates in SRD patients.
引用
- Erfe JM, Malaisrie SC, Andrei AC, et al. Outcomes of Sutureless/Rapid Deployment Valves Compared to Traditional Bioprosthetic Aortic Valves. Ann Thorac Surg. 2020. PMID: 32987022. doi:10.1016/j.athoracsur.2020.07.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。